CME Group Inc. (NASDAQ:CME) Insider Sunil Cutinho Sells 4,500 Shares

CME Group Inc. (NASDAQ:CMEGet Free Report) insider Sunil Cutinho sold 4,500 shares of the company’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the completion of the transaction, the insider now directly owns 27,053 shares in the company, valued at approximately $6,131,291.92. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

CME Group Trading Up 0.1 %

CME Group stock traded up $0.17 during trading hours on Wednesday, reaching $227.26. The company had a trading volume of 1,211,235 shares, compared to its average volume of 1,921,584. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The company has a 50-day moving average price of $219.69 and a 200 day moving average price of $209.10. The firm has a market cap of $81.83 billion, a price-to-earnings ratio of 25.84, a P/E/G ratio of 7.76 and a beta of 0.55. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $230.36.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The business’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the firm earned $2.25 EPS. Equities analysts forecast that CME Group Inc. will post 10.04 earnings per share for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were paid a $1.15 dividend. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.02%. CME Group’s dividend payout ratio (DPR) is currently 52.33%.

Hedge Funds Weigh In On CME Group

A number of large investors have recently bought and sold shares of the stock. Harbor Capital Advisors Inc. increased its stake in CME Group by 0.6% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock worth $1,723,000 after purchasing an additional 45 shares during the period. CVA Family Office LLC increased its stake in shares of CME Group by 11.8% during the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock valued at $96,000 after buying an additional 46 shares during the period. Lester Murray Antman dba SimplyRich increased its stake in shares of CME Group by 0.7% during the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after buying an additional 50 shares during the period. Essex LLC increased its stake in shares of CME Group by 3.3% during the first quarter. Essex LLC now owns 1,649 shares of the financial services provider’s stock valued at $355,000 after buying an additional 52 shares during the period. Finally, Quent Capital LLC increased its stake in shares of CME Group by 10.2% during the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock valued at $131,000 after buying an additional 55 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have weighed in on CME. The Goldman Sachs Group upped their target price on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research note on Thursday, October 3rd. Piper Sandler lifted their price target on CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research report on Monday. Bank of America lifted their price target on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Barclays lifted their price target on CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a research report on Thursday, October 24th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research report on Thursday, October 24th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $222.73.

Check Out Our Latest Analysis on CME Group

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.